Insmed Inc Stock Z Score

INSM Stock

USD 75.16 0.72 0.95%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Insmed Piotroski F Score and Insmed Valuation analysis.

At this time, Insmed's Capital Surpluse is very stable compared to the past year. As of the 29th of November 2024, Capital Expenditures is likely to grow to about 14 M, while Net Working Capital is likely to drop about 667.3 M. At this time, Insmed's Cost Of Revenue is very stable compared to the past year. As of the 29th of November 2024, Total Operating Expenses is likely to grow to about 996.7 M, though EBIT is likely to grow to (632.1 M).

Insmed Inc Company Z Score Analysis

Insmed's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Insmed Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Insmed is extremely important. It helps to project a fair market value of Insmed Stock properly, considering its historical fundamentals such as Z Score. Since Insmed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Insmed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Insmed's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Short Term Investments	Total Liab	Total Current Assets	Common Stock	Good Will	Intangible Assets	Property Plant Equipment	Current Deferred Revenue	Net Receivables	Short Term Debt	Long Term Debt	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		-0.34	0.59	-0.96	0.92	0.61	0.95	0.99	0.9	0.88	0.54	0.91	-0.68	0.91	-0.04	0.95	-0.49	0.97	0.44	0.93	0.6	0.95	0.93	0.93
Total Stockholder Equity	-0.34		-0.93	0.5	-0.57	-0.89	-0.62	-0.3	-0.14	-0.53	0.09	-0.34	0.39	-0.61	0.28	-0.62	0.88	-0.41	0.29	-0.66	-0.05	-0.25	-0.31	-0.53
Net Debt	0.59	-0.93		-0.73	0.78	0.97	0.81	0.54	0.39	0.76	0.13	0.6	-0.57	0.83	-0.25	0.81	-0.85	0.67	-0.09	0.84	0.21	0.49	0.51	0.74
Retained Earnings	-0.96	0.5	-0.73		-0.97	-0.75	-0.97	-0.94	-0.88	-0.9	-0.49	-0.94	0.66	-0.97	-0.01	-0.96	0.54	-0.99	-0.43	-0.96	-0.63	-0.84	-0.83	-0.94
Accounts Payable	0.92	-0.57	0.78	-0.97		0.79	0.96	0.9	0.81	0.88	0.41	0.88	-0.75	0.95	0.0	0.95	-0.6	0.95	0.34	0.95	0.54	0.8	0.8	0.93
Short Term Investments	0.61	-0.89	0.97	-0.75	0.79		0.81	0.57	0.43	0.78	0.22	0.59	-0.52	0.82	-0.17	0.8	-0.78	0.69	0.01	0.84	0.21	0.46	0.48	0.73
Total Liab	0.95	-0.62	0.81	-0.97	0.96	0.81		0.93	0.79	0.92	0.42	0.88	-0.7	0.97	-0.13	1.0	-0.7	0.95	0.27	1.0	0.52	0.87	0.88	0.95
Total Current Assets	0.99	-0.3	0.54	-0.94	0.9	0.57	0.93		0.91	0.84	0.52	0.9	-0.64	0.88	-0.02	0.93	-0.45	0.95	0.46	0.91	0.62	0.94	0.93	0.9
Common Stock	0.9	-0.14	0.39	-0.88	0.81	0.43	0.79	0.91		0.74	0.6	0.85	-0.53	0.78	0.16	0.79	-0.25	0.89	0.61	0.77	0.74	0.82	0.8	0.84
Good Will	0.88	-0.53	0.76	-0.9	0.88	0.78	0.92	0.84	0.74		0.65	0.74	-0.68	0.9	-0.08	0.91	-0.65	0.87	0.31	0.91	0.4	0.82	0.8	0.89
Intangible Assets	0.54	0.09	0.13	-0.49	0.41	0.22	0.42	0.52	0.6	0.65		0.37	-0.22	0.39	0.12	0.41	-0.14	0.46	0.45	0.39	0.3	0.48	0.46	0.42
Property Plant Equipment	0.91	-0.34	0.6	-0.94	0.88	0.59	0.88	0.9	0.85	0.74	0.37		-0.6	0.91	-0.02	0.87	-0.37	0.95	0.45	0.86	0.66	0.81	0.78	0.86
Current Deferred Revenue	-0.68	0.39	-0.57	0.66	-0.75	-0.52	-0.7	-0.64	-0.53	-0.68	-0.22	-0.6		-0.7	0.32	-0.69	0.51	-0.66	0.0	-0.69	-0.14	-0.74	-0.71	-0.8
Net Receivables	0.91	-0.61	0.83	-0.97	0.95	0.82	0.97	0.88	0.78	0.9	0.39	0.91	-0.7		-0.1	0.96	-0.64	0.95	0.3	0.97	0.49	0.81	0.8	0.94
Short Term Debt	-0.04	0.28	-0.25	-0.01	0.0	-0.17	-0.13	-0.02	0.16	-0.08	0.12	-0.02	0.32	-0.1		-0.13	0.36	0.04	0.57	-0.14	0.48	-0.13	-0.15	-0.13
Long Term Debt	0.95	-0.62	0.81	-0.96	0.95	0.8	1.0	0.93	0.79	0.91	0.41	0.87	-0.69	0.96	-0.13		-0.71	0.94	0.27	1.0	0.52	0.87	0.89	0.95
Net Tangible Assets	-0.49	0.88	-0.85	0.54	-0.6	-0.78	-0.7	-0.45	-0.25	-0.65	-0.14	-0.37	0.51	-0.64	0.36	-0.71		-0.45	0.32	-0.73	-0.11	-0.51	-0.59	-0.64
Capital Surpluse	0.97	-0.41	0.67	-0.99	0.95	0.69	0.95	0.95	0.89	0.87	0.46	0.95	-0.66	0.95	0.04	0.94	-0.45		0.49	0.94	0.64	0.86	0.83	0.92
Deferred Long Term Liab	0.44	0.29	-0.09	-0.43	0.34	0.01	0.27	0.46	0.61	0.31	0.45	0.45	0.0	0.3	0.57	0.27	0.32	0.49		0.25	0.47	0.3	0.24	0.25
Long Term Debt Total	0.93	-0.66	0.84	-0.96	0.95	0.84	1.0	0.91	0.77	0.91	0.39	0.86	-0.69	0.97	-0.14	1.0	-0.73	0.94	0.25		0.5	0.84	0.85	0.94
Short Long Term Debt	0.6	-0.05	0.21	-0.63	0.54	0.21	0.52	0.62	0.74	0.4	0.3	0.66	-0.14	0.49	0.48	0.52	-0.11	0.64	0.47	0.5		0.54	0.51	0.54
Net Invested Capital	0.95	-0.25	0.49	-0.84	0.8	0.46	0.87	0.94	0.82	0.82	0.48	0.81	-0.74	0.81	-0.13	0.87	-0.51	0.86	0.3	0.84	0.54		0.99	0.9
Net Working Capital	0.93	-0.31	0.51	-0.83	0.8	0.48	0.88	0.93	0.8	0.8	0.46	0.78	-0.71	0.8	-0.15	0.89	-0.59	0.83	0.24	0.85	0.51	0.99		0.89
Capital Stock	0.93	-0.53	0.74	-0.94	0.93	0.73	0.95	0.9	0.84	0.89	0.42	0.86	-0.8	0.94	-0.13	0.95	-0.64	0.92	0.25	0.94	0.54	0.9	0.89

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict Insmed

According to the company's disclosures, Insmed Inc has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Insmed ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Insmed's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Insmed's managers, analysts, and investors.

Environmental

Governance

Social

Insmed Institutional Holders

Institutional Holdings refers to the ownership stake in Insmed that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Insmed's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Insmed's value.

		Shares
Artisan Partners Limited Partnership	2024-09-30	2.9 M
Macquarie Group Ltd	2024-06-30	2.7 M
Franklin Resources Inc	2024-09-30	2.7 M
Ameriprise Financial Inc	2024-06-30	2.5 M
Suvretta Capital Management, Llc	2024-06-30	2.5 M
Alliancebernstein L.p.	2024-06-30	2.5 M
William Blair Investment Management, Llc	2024-09-30	2.4 M
T. Rowe Price Investment Management,inc.	2024-09-30	2.3 M
Hhg Plc	2024-06-30	2.1 M
Vanguard Group Inc	2024-09-30	17.1 M
Blackrock Inc	2024-06-30	14.3 M

Insmed Fundamentals

	Return On Equity	-8.91
	Return On Asset	-0.26
	Profit Margin	(2.52) %
	Operating Margin	(2.13) %
	Current Valuation	13.11 B
	Shares Outstanding	178.9 M
	Shares Owned By Insiders	0.91 %
	Shares Owned By Institutions	99.09 %
	Number Of Shares Shorted	12.1 M
	Price To Earning	(8.70) X
	Price To Book	28.08 X
	Price To Sales	39.58 X
	Revenue	305.21 M
	Gross Profit	190.23 M
	EBITDA	(654.74 M)
	Net Income	(749.57 M)
	Cash And Equivalents	554.87 M
	Cash Per Share	4.62 X
	Total Debt	1.2 B
	Current Ratio	5.93 X
	Book Value Per Share	2.70 X
	Cash Flow From Operations	(536.25 M)
	Short Ratio	8.80 X
	Earnings Per Share	(5.55) X
	Target Price	89.4
	Number Of Employees	912
	Beta	1.12
	Market Capitalization	13.58 B
	Total Asset	1.33 B
	Retained Earnings	(3.45 B)
	Working Capital	703.43 M
	Current Asset	28.15 M
	Current Liabilities	3.89 M
	Net Asset	1.33 B

About Insmed Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Insmed Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Insmed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Insmed Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:

How To Invest In Insmed

Details

Is Insmed Stock a good investment?

Details

What is Insmed's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Insmed Piotroski F Score and Insmed Valuation analysis.

You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(5.55)

Revenue Per Share

2.206

Quarterly Revenue Growth

0.182

Return On Assets

(0.26)

Return On Equity

(8.91)

The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Insmed Inc Stock Z Score

Insmed Inc Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Insmed Z Score Driver Correlations

Insmed ESG Sustainability

Insmed Institutional Holders

Insmed Fundamentals

About Insmed Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY